Pathologische Kreatinkinasewerte (CK) und Zwangsmaßnahmen in der Akutpsychiatrie

Zusammenfassung

Ziel der Studie war, die Assoziation von Zwangsmaßnahmen, erhoben mit der Staff Observation Aggression Scale (SOAS-R) als Folge von Aggressivität mit pathologischen Kreatinkinasewerten (CK-Werten) bei 317 akutpsychiatrischen Patienten zu untersuchen. In einer CHAID-Analyse war ein pathologischer CK-Wert assoziiert mit der Durchführung von Zwangsmaßnahmen; covariierende Variablen waren „Aggressionsanamnese“ und „Hauptdiagnose“. In der ROC-Analyse zeigte sich für pathologische CK-Werte bezüglich späterer Durchführung von Zwangsmaßnahmen eine Sensitivität von 73,5 % und eine Spezifität von 67,5 %.

Abstract

The aim of this study was to investigate the association of compulsory measures (CM) with pathological Creatine Kinase (CK) levels in 317 patients admitted to a secure psychiatric ward. The assumptions is that CK-activity is increased prior to administration of CM because increases in CK-levels may represent aggressive behaviour as precursors of a higher chance of administrating CM. The CK-levels were assessed immediately following admission. During the course of the patients’ stay the frequency of different CM was assessed by the use of the Staff Observation Aggression Scale. In a CHAID analysis pathological CK-levels were associated with subsequent administration of CM. Lifetime aggression and main diagnosis were associated with administration of CM as well. In a ROC analysis concerning pathological CK-activity the AUC for subsequent administration of CM was 70.5 % with a sensitivity of 73.5 % and a specifity of 67.5 %. Despite some methodological shortcomings the study indicates that it could be useful to measure CK-activity at the time of admission because pathological levels may indicate an increased probability of administration of CM subsequent to aggressive behaviour.

Schlüsselwörter

Kreatinkinaseaktivität - Agitiertheit - Aggression - Zwangsmaßnahmen - Prädiktion

Keywords

creatine kinase activity - agitation - aggression - compulsory measures - prediction

• Literatur

• 1 Smolka M, Klimitz H, Scheuring B et al. Zwangsmaßnahmen in der Psychiatrie aus der Sicht der Patienten: Eine prospektive Untersuchung. Nervenarzt 1997; 68: 888-895
• 2 Frajo-Apor B, Stippler M, Meise U. „Etwas Erniedrigenderes kann dir eigentlich in der Psychiatrie nicht passieren“ Auswertung von 14 Leitfadeninterviews mit psychiatrischen Patienten über ihre Erfahrungen mit mechanischer Fixierung. Psychiat Prax 2011; 38: 293-299
• 3 Längle G, Bayer W. Psychiatrische Zwangsbehandlung und die Sichtweise der Patienten. Psychiat Prax 2007; 34 (Suppl. 02) S203-S207
• 4 Spengler A, Koller M. Zwingend ohne Zwang?. Psychiat Prax 2012; 39: 313-315
• 5 Spitz TR, Hillbrand M, Foster HG et al. Ethnicity, aggression and serum creatinine kinase in hospitalized male forensic patients. Ethnicity dis 1997; 7: 259-270
• 6 Hillbrand M, Spitz TR, Foster HG et al. Creatine kinase elevations and aggressive behavior in hospitalised forensic patients. Psychiatr Q 1998; 69: 69-82
• 7 Grube M, Liszka R, Weigand-Tomiuk H. Creatine kinase (CK) associated with aggressive behaviour in psychiatric patients. Gen Hosp Psychiatry 2008; 30: 564-571
• 8 Stein W. Creatinkinase (Gesamtaktivität) Creatinkinase-Isoenzyme und -varianten. In: Thomas L, Hrsg. Labor und Diagnose. Frankfurt a. M.: TH-Books Verlagsgesellschaft mbH; 2005: 88-96
• 9 Krüger E, Lohse H. Serum creatinphosphokinase (CPK) in endogenic psychoses. Psychiatr Neurol Med Psychol 1975; 27: 140-146
• 10 Soni SD. Serum creatine phosphokinase in acute psychosis. Br J Psychiatry 1976; 128: 181-183
• 11 Linke E, Stracke E, Pannenborg H. Serum creatine kinase activity in psychoses. Psychiatr Neurol Med Psychol 1979; 31: 11-19
• 12 Taylor JR, Abichandani L. Creatine phosphokinase elevations and psychiatric symptomatology. Biol Psychiatry 1980; 15: 865-870
• 13 Schubert DS, Brocco K, Miller FT et al. Serum creatine phosphokinase levels in patients meeting the St. Louis research diagnostic criteria for schizophrenia. Am J Psychiatry 1982; 139: 491-493
• 14 Northoff G, Wenke J, Pflug B. Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients. Psychol Med 1996; 26: 547-553
• 15 Meltzer HY, Cola PA, Parsa M. Marked elevations of creatine kinase activity associated with antipsychotic drug treatment. Neuropsychopharmacology 1996; 15: 395-405
• 16 Hatta K, Takahashi T, Nakamura H et al. Abnormal physiological conditions in acute schizophrenic patients on emergency admissions: dehydration, hypokalemia, leucocytosis and elevated serum muscle enzymes. Eur Arch Psychiatry Clin Neurosci 1998; 248: 180-188
• 17 Blumensohn R, Yoran-Hegesh R, Golubchik P et al. Elevated serum creatinine activity in adolescent psychiatric inpatients on admission. Int Clin Psychopharmacol 1998; 13: 269-272
• 18 Terao T, Matsuda S, Kojima H et al. Incidence and risk factors of benign creatine phosphokinase elevations in chronic psychiatric patients. Neuropsychobiology 1999; 39: 173-180
• 19 Marcus EL, Vass A, Zislin J. Marked elevation of serum creatinine associated with olanzapine therapy. Ann Pharmacother 1999; 33: 697-700
• 20 Hermesh H, Stein D, Manor I et al. Serum creatinine kinase levels in untreated adolescents during acute psychosis. J Am Acad Child Adolesc Psychiatry 2002; 41: 1045-1053
• 21 Nijman HLI, Muris P, Merckelbach HLGJ et al. The staff observation aggression scale – revised (SOAS-R). Aggressive Behav 1999; 25: 197-209
• 22 Palmstierna T, Wistedt B. Staff Observation Aggression Scale. SOAS: presentation and evaluation. Acta psychiatr scand 1987; 76: 657-663
• 23 Nijman HLI, Palmstierna T, Almvik R et al. Fiften years of research with the staff observation aggression scale: a review. Acta psychiatr scand 2005; 111: 12-21
• 24 Hare RD. The Hare psychopathy check list. Revised, 2nd. edn. Toronto: Multi Health Systems; 2003
• 25 Hart SD, Cox DN, Hare RD. Hare PCL:SV German manual supplement. – übersetzt und ins Deutsche übertragen von Roland Freese. North Tonawonda, Toronto: MHS; 1999
• 26 Douglas KS, Ogloff JRP, Nicholls TL et al. Assessing risk for violence among psychiatric patients: the HCR-20 violence risk assessment schema and the Psychopathy Checklist – Screening Version. J Cons Clin Psychol 1999; 67: 917-930
• 27 Skeem Jl, Mulvey EP. Psychopathy and community violence among civil psychiatric patients: results from the MacArthur risk assessment study. J cons clin psychol 2001; 69: 358-374
• 28 Douglas KS, Strand S, Belfrage H et al. Reliability and validity evaluation of the Psychopathy Checklist – Screening Version (PCL:SV) in Swedish correctional and forensic psychiatric samples. Assessment 2005; 12: 145-161
• 29 National Institute of Mental Health. CGI-Clinical Global Impressions. In: Guy W, Bonato RR, eds. Manual for the ECDEU assessment battery. 2nd. rev. ed. Chevy Chase, MD: NIMH; 1970: 12/1-12/6
• 30 Martin V, Bernhardsgrütter R, Göbel R et al. Ein Vergleich von Schweizer und deutschen Kliniken in Bezug auf die Anwendung von Fixierung und Isolierung. Psychiat Prax 2007; 34 (Suppl. 02) S212-S217
• 31 Hall HV, Ebert R. Violence prediction: Guidelines for the forensic practitioner. Springfield, Illinois: CC Thomas; 1987
• 32 Steinert T. Aggressives Verhalten: Prävention und Intervention. In: Schmid-Zadel R, Kruckenberg P. Kooperation und Verantwortung in der Gemeindepsychiatrie. Bonn: Aktion Psychisch Kranke; 2009: 255-262
• 33 Steinert T. Nach 200 Jahren Psychiatrie: Sind Fixierungen in Deutschland unvermeidlich?. Psychiat Prax 2011; 38: 348-351
• 34 Sollberger D, Lang UE. Psychiatrie mit offenen Türen, Teil 2: Therapeutische Herausforderungen. Nervenarzt DOI: DOI: 10.1007/s00115-013-3770-3.